Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Myriad Genetics Acquires Exclusive Rights to Pancreatic Cancer Gene Patents From Johns Hopkins
Myriad, 10/16/09
Myriad Genetics, Inc. announced it has obtained from Johns Hopkins University a world–wide, exclusive license to patents covering mutations in the PALB2 gene that increase an individual's risk for developing pancreatic cancer later in life.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09
Philips developing digital pathology solutions
Canadian Healthcare Technology, 11/20/09
New director at CHUM hired from France
Canadian Healthcare Technology, 11/20/09
Article Search
Sponsor


See Latest Articles


